Company
Sidewinder Therapeutics
| Industry | biopharmaceutical company developing ADCs (antibody-drug conjugates) for the treatment of cancer |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Sidewinder Therapeutics | Series B | 2026-04-09 |
Company
| Industry | biopharmaceutical company developing ADCs (antibody-drug conjugates) for the treatment of cancer |
|---|
| Company | Round | Date |
|---|---|---|
| Sidewinder Therapeutics | Series B | 2026-04-09 |